XML 19 R8.htm IDEA: XBRL DOCUMENT v3.25.2
CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY - USD ($)
shares in Millions, $ in Millions
Total
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Accumulated Other Comprehensive Loss
Treasury Stock
Balance at beginning of period (in shares) at Dec. 31, 2023   187.0        
Balance at beginning of period at Dec. 31, 2023 $ 3,878.2 $ 1.9 $ 3,032.7 $ 947.5 $ (47.5) $ (56.4)
Treasury stock, balance at beginning of period (in shares) at Dec. 31, 2023           (3.3)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Acquisition of treasury stock (in shares)           (0.4)
Acquisition of treasury stock (6.2)         $ (6.2)
Exercise of stock options 0.0   (0.1)     $ 0.1
Compensatory awards released from restriction (in shares)           0.8
Compensatory awards released from restriction 0.0   (14.0)     $ 14.0
Share-based compensation 13.1   13.1      
Equity adjustment from foreign currency translation (14.2)       (14.2)  
Change in fair value of derivative instruments, net of tax 9.6       9.6  
Net income 6.5     6.5    
Balance at end of period (in shares) at Mar. 31, 2024   187.0        
Balance at end of period at Mar. 31, 2024 3,887.0 $ 1.9 3,031.7 954.0 (52.1) $ (48.5)
Treasury stock, balance at end of period (in shares) at Mar. 31, 2024           (2.9)
Balance at beginning of period (in shares) at Dec. 31, 2023   187.0        
Balance at beginning of period at Dec. 31, 2023 3,878.2 $ 1.9 3,032.7 947.5 (47.5) $ (56.4)
Treasury stock, balance at beginning of period (in shares) at Dec. 31, 2023           (3.3)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Impact from dissolution of foreign subsidiaries 3.4          
Net income 68.6          
Balance at end of period (in shares) at Jun. 30, 2024   187.0        
Balance at end of period at Jun. 30, 2024 3,933.5 $ 1.9 3,017.2 1,016.1 (49.6) $ (52.1)
Treasury stock, balance at end of period (in shares) at Jun. 30, 2024           (3.2)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Foreign currency translation adjustments (17.7)          
Balance at beginning of period (in shares) at Mar. 31, 2024   187.0        
Balance at beginning of period at Mar. 31, 2024 3,887.0 $ 1.9 3,031.7 954.0 (52.1) $ (48.5)
Treasury stock, balance at beginning of period (in shares) at Mar. 31, 2024           (2.9)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Acquisition of treasury stock (in shares)           (1.6)
Acquisition of treasury stock (25.1)         $ (25.1)
Compensatory awards released from restriction (in shares)           1.3
Compensatory awards released from restriction 0.0   (21.5)     $ 21.5
Share-based compensation 7.0   7.0      
Equity adjustment from foreign currency translation (3.5)          
Change in fair value of derivative instruments, net of tax 2.6       2.6  
Impact from dissolution of foreign subsidiaries 3.4       3.4  
Net income 62.1     62.1    
Balance at end of period (in shares) at Jun. 30, 2024   187.0        
Balance at end of period at Jun. 30, 2024 3,933.5 $ 1.9 3,017.2 1,016.1 (49.6) $ (52.1)
Treasury stock, balance at end of period (in shares) at Jun. 30, 2024           (3.2)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Foreign currency translation adjustments (3.5)       (3.5)  
Balance at beginning of period (in shares) at Dec. 31, 2024   186.2        
Balance at beginning of period at Dec. 31, 2024 $ 2,407.7 $ 1.9 3,032.8 (500.2) (76.0) $ (50.8)
Treasury stock, balance at beginning of period (in shares) at Dec. 31, 2024 (3.1)         (3.1)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Acquisition of treasury stock (in shares)           (0.5)
Acquisition of treasury stock $ (3.3)         $ (3.3)
Compensatory awards released from restriction (in shares)           1.1
Compensatory awards released from restriction 0.0   (17.7)     $ 17.7
Share-based compensation 7.0   7.0      
Equity adjustment from foreign currency translation 18.2       18.2  
Change in fair value of derivative instruments, net of tax (5.1)       (5.1)  
Net income 2.1     2.1    
Balance at end of period (in shares) at Mar. 31, 2025   186.2        
Balance at end of period at Mar. 31, 2025 2,426.6 $ 1.9 3,022.1 (498.1) (62.9) $ (36.4)
Treasury stock, balance at end of period (in shares) at Mar. 31, 2025           (2.5)
Balance at beginning of period (in shares) at Dec. 31, 2024   186.2        
Balance at beginning of period at Dec. 31, 2024 $ 2,407.7 $ 1.9 3,032.8 (500.2) (76.0) $ (50.8)
Treasury stock, balance at beginning of period (in shares) at Dec. 31, 2024 (3.1)         (3.1)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Impact from dissolution of foreign subsidiaries $ 13.8          
Net income 22.4          
Balance at end of period (in shares) at Jun. 30, 2025   186.2        
Balance at end of period at Jun. 30, 2025 $ 2,488.1 $ 1.9 3,027.3 (477.8) (28.7) $ (34.6)
Treasury stock, balance at end of period (in shares) at Jun. 30, 2025 (2.3)         (2.3)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Foreign currency translation adjustments $ 45.4          
Balance at beginning of period (in shares) at Mar. 31, 2025   186.2        
Balance at beginning of period at Mar. 31, 2025 2,426.6 $ 1.9 3,022.1 (498.1) (62.9) $ (36.4)
Treasury stock, balance at beginning of period (in shares) at Mar. 31, 2025           (2.5)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Compensatory awards released from restriction (in shares)           0.2
Compensatory awards released from restriction 0.0   (1.8)     $ 1.8
Share-based compensation 7.0   7.0      
Change in fair value of derivative instruments, net of tax (6.8)       (6.8)  
Impact from dissolution of foreign subsidiaries 13.8       13.8  
Net income 20.3     20.3    
Balance at end of period (in shares) at Jun. 30, 2025   186.2        
Balance at end of period at Jun. 30, 2025 $ 2,488.1 $ 1.9 $ 3,027.3 $ (477.8) (28.7) $ (34.6)
Treasury stock, balance at end of period (in shares) at Jun. 30, 2025 (2.3)         (2.3)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Foreign currency translation adjustments $ 27.2       $ 27.2